secwatch / observer
8-K filed December 22, 2021, 6:59 PM ET ticker SMTI CIK 0000714256
leadership confidence high sentiment neutral materiality 0.75

Sanara MedTech CEO J. Michael Carmena retires; Eric Tanzberger appointed to board

Sanara MedTech Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

J. Michael Carmena

Principal Executive Officer
SMTI · Sanara MedTech Inc.
Effective
2021-12-31
Filed
December 22, 2021, 6:59 PM ET
Mr. Carmena delivered a letter providing notice of his resignation from his position as Principal Executive Officer of the Company and as a member of the Board of Directors (the “Board”), effective December 31, 2021.
Appointed

Eric Tanzberger

Director
SMTI · Sanara MedTech Inc.
Effective
2022-01-01
Filed
December 22, 2021, 6:59 PM ET
the Board appointed Eric Tanzberger as a director of the Company, effective January 1, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

J. Michael Carmena resigned as Principal Executive Officer at Sanara MedTech Inc..

Action
resigned
Role
Principal Executive Officer
Exact text from the filing
Mr. Carmena delivered a letter providing notice of his resignation from his position as Principal Executive Officer of the Company and as a member of the Board of Directors (the “Board”), effective December 31, 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Tanzberger was appointed as Director at Sanara MedTech Inc..

Action
appointed
Role
Director
Exact text from the filing
the Board appointed Eric Tanzberger as a director of the Company, effective January 1, 2022
View on SEC.gov

Sanara MedTech Inc. filing history →

Source: SEC EDGAR
accession 0001493152-21-032276
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.